Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients.

Journal of Aerosol Medicine and Pulmonary Drug Delivery
Wilfried De BackerFabrizia Mariotti

Abstract

When inhaling medication, it is essential that drug particles are delivered to all sites of lung inflammation, including the peripheral airways. The aim of this study was to assess the lung deposition and lung distribution of beclomethasone dipropionate (BDP)/formoterol (100/6 microg), both dissolved in hydrofluoroalkane (HFA) and delivered by pressurized metered dose inhaler (pMDI) in healthy subjects, asthmatic, and chronic obstructive pulmonary disease (COPD) patients, to investigate how the in vitro characteristics of the formulation translate into the in vivo performance in diseases with different airway obstruction. Healthy volunteers (n = 8), persistent asthmatics (n = 8), and patients with stable COPD (n = 8) completed this open-label, single-dose parallel-group study. Each patient received one single treatment of four puffs of (99 m)Tc-labeled BDP/formoterol formulation. The correlation between particle size distribution of radioactivity and of the drugs in the radiolabeled formulation was validated. Intra- and extrapulmonary deposition, amount of exhaled drug, and the central to peripheral ratio (C/P) were calculated immediately after inhalation. Patients' lung function and pharmacokinetic parameters were also assesse...Continue Reading

References

Nov 1, 1989·The American Review of Respiratory Disease·D SpinaR G Goldie
Mar 30, 1995·The New England Journal of Medicine·P J Barnes
Sep 1, 1996·American Journal of Respiratory and Critical Care Medicine·I M AdcockP J Barnes
Jul 1, 1997·The Journal of Allergy and Clinical Immunology·Q HamidJ C Hogg
Apr 15, 1999·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·K R ChapmanM Briggs
Apr 25, 2001·British Journal of Clinical Pharmacology·H Chrystyn
Dec 12, 2001·Respiratory Research·M K TulicQ Hamid
Jun 25, 2004·The New England Journal of Medicine·James C HoggPeter D Paré
Sep 30, 2005·American Journal of Respiratory and Critical Care Medicine·Omar S UsmaniPeter J Barnes
Dec 29, 2005·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Chet L LeachRobert J Boudreau
Mar 22, 2006·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·H HauberRon Olivenstein
Aug 8, 2006·Pulmonary Pharmacology & Therapeutics·D AcerbiI Kottakis
Nov 17, 2006·The European Respiratory Journal·A PapiUNKNOWN Inhaled Combination Asthma Treatment versus SYmbicort (ICAT SY) Study Group
Mar 6, 2007·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Roberta RazzettiGiuseppe Rossoni
Sep 27, 2007·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Sabine HäussermannThomas Meyer
Feb 12, 2009·Therapeutics and Clinical Risk Management·Gabriele NicoliniLeonardo M Fabbri

❮ Previous
Next ❯

Citations

Dec 19, 2012·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Stephen NewmanKirby L Zeman
Dec 12, 2012·Respiratory Research·Claudio TerzanoUNKNOWN PRISMA (PRospectIve Study on asthMA control) Study Group
Nov 10, 2011·International Journal of Chronic Obstructive Pulmonary Disease·Panagiota TzaniDario Olivieri
Feb 5, 2013·Journal of Asthma and Allergy·Nicola ScichiloneVincenzo Bellia
Aug 15, 2014·Advances in Therapy·Anna Bodzenta-Łukaszyk, Marek Kokot
May 14, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Michael Yifei YangHak-Kim Chan
Dec 8, 2011·Inhalation Toxicology·Philip J KuehlJacob D McDonald
May 8, 2014·Expert Review of Respiratory Medicine·David Price, Elizabeth V Hillyer
Aug 28, 2014·Expert Review of Respiratory Medicine·Daniel LangerDenis E O'Donnell
Jan 31, 2012·Expert Review of Respiratory Medicine·Toby G D Capstick, Ian J Clifton
Mar 30, 2013·COPD·James B FinkRick Hodder
Jan 30, 2016·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Nicolas Roche, P N Richard Dekhuijzen
Mar 31, 2015·Advanced Drug Delivery Reviews·Stephen Dubsky, Andreas Fouras
Mar 29, 2013·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Brian Lipworth
Oct 18, 2012·Pulmonary Pharmacology & Therapeutics·Nicola ScichiloneNicola Sverzellati
Mar 5, 2016·Expert Review of Respiratory Medicine·Ernesto CrisafulliAlfredo Chetta
May 28, 2011·British Journal of Clinical Pharmacology·Dave SinghAntonio Rusca
Sep 12, 2015·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Francesca ButtiniIrene Pasquali
Jun 24, 2014·Respiratory Medicine·J A WedzichaUNKNOWN FORWARD Investigators
Mar 26, 2013·Pulmonary Pharmacology & Therapeutics·Neil BarnesUNKNOWN FACTO (Foster® As Complete Treatment Option) Study Group
Sep 18, 2014·Allergy, Asthma & Immunology Research·Omar S Usmani
Jul 23, 2014·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Serpil BulacHulya Ellidokuz
Oct 23, 2010·Respiratory Medicine·P M A CalverleyV Brusasco
Jun 14, 2016·Expert Opinion on Drug Delivery·Bita HajianWilfried De Backer
Jul 23, 2016·Annals of Intensive Care·Jonathan DugernierPierre-François Laterre
Nov 4, 2016·Pharmaceutical Research·Francesca ButtiniPaolo Colombo
Jan 15, 2017·The Journal of Allergy and Clinical Immunology·Sunny JabbalBrian Lipworth
Feb 25, 2017·Scientific Reports·Sophie PerinelJean M Vergnon
Apr 10, 2016·Therapeutic Advances in Respiratory Disease·Katharina MarthWolfgang Pohl

❮ Previous
Next ❯

Software Mentioned

SAS
DeclareMathSizes
Modulite
CITDAS

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.